David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
3226
CALL
DELISTED
Radius Recycling
RDUS
| $278K | ﹤0.01% |
+8,300
| New | +$243K |
|
3227
Ingles Markets
IMKTA
$1.62B
| $277K | ﹤0.01% |
8,007
-29,434
| -79% | -$801K |
|
|
REV
3228
DELISTED
Revlon, Inc.
REV
| $277K | ﹤0.01% |
+12,714
| New | +$282K |
|
3229
PRA Group
PRAA
$759M
| $276K | ﹤0.01% |
+8,328
| New | +$264K |
|
3230
Intrepid Potash
IPI
$510M
| $275K | ﹤0.01% |
5,775
-7,573
| -57% | -$295K |
|
3231
PUT
iRhythm Holdings
IRTC
$4.13B
| $275K | ﹤0.01% |
+4,900
| New | +$256K |
|
3232
Costamare
CMRE
$1.88B
| $273K | ﹤0.01% |
47,374
+31,002
| +189% | +$184K |
|
3233
Hyster-Yale Materials Handling
HY
$614M
| $273K | ﹤0.01% |
+3,206
| New | +$264K |
|
3234
PDS Biotechnology
PDSB
$12.1M
| $273K | ﹤0.01% |
1,456
+170
| +13% | +$34.2K |
|
3235
PUT
Pilgrim's Pride
PPC
$7.57B
| $273K | ﹤0.01% |
+8,800
| New | +$287K |
|
|
RAD
3236
DELISTED
Rite Aid Corporation
RAD
| $273K | ﹤0.01% |
6,937
-801
| -10% | -$28.6K |
|
|
MDCO
3237
CALL
DELISTED
Medicines Co
MDCO
| $273K | ﹤0.01% |
10,000
| – | – |
|
3238
CALL
AGCO
AGCO
$7.71B
| $271K | ﹤0.01% |
3,800
| – | – |
|
|
USCR
3239
DELISTED
U S Concrete, Inc.
USCR
| $271K | ﹤0.01% |
3,240
-3,789
| -54% | -$298K |
|
3240
CALL
Wheaton Precious Metals
WPM
$72.8B
| $270K | ﹤0.01% |
12,200
-2,400
| -16% | -$50K |
|
3241
CALL
Curtiss-Wright
CW
$22.7B
| $268K | ﹤0.01% |
+2,200
| New | +$260K |
|
3242
CALL
Fabrinet
FN
$15.1B
| $267K | ﹤0.01% |
+9,300
| New | +$308K |
|
3243
Ocular Therapeutix
OCUL
$2.37B
| $267K | ﹤0.01% |
60,057
+2,911
| +5% | +$14.9K |
|
|
EGRX
3244
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $267K | ﹤0.01% |
+5,000
| New | +$278K |
|
|
KEM
3245
PUT
DELISTED
KEMET Corporation
KEM
| $267K | ﹤0.01% |
17,700
-47,300
| -73% | -$901K |
|
3246
CALL
HF Sinclair
DINO
$16.9B
| $266K | ﹤0.01% |
+5,200
| New | +$220K |
|
3247
CALL
Lands' End
LE
$377M
| $266K | ﹤0.01% |
13,600
| – | – |
|
|
ENTL
3248
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $266K | ﹤0.01% |
10,909
-2,288
| -17% | -$44K |
|
3249
Alaunos Therapeutics
TCRT
$4.37M
| $264K | ﹤0.01% |
425
-531
| -56% | -$382K |
|
3250
Diageo
DEO
$53.4B
| $263K | ﹤0.01% |
+1,800
| New | +$248K |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.